Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Benign Prostatic Enlargement (BPE)”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT02434575
What this trial is testing

UK ROPE Register Study

Who this might be right for
Lower Urinary Tract Symptoms
Cardiff and Vale University Health Board 318
Large-scale testing (Phase 3)Study completedNCT01566292
What this trial is testing

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

Who this might be right for
Benign Prostatic Hyperplasia (BPH)Benign Prostatic Enlargement (BPE)
Catholic University of the Sacred Heart 33
Not applicableUnknownNCT02849522
What this trial is testing

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).

Who this might be right for
Lower Urinary Tract Symptoms Caused by Benign Prostatic Enlargement (LUTS BPE)Prostate Artery Embolisation (PAE)Transurethral Resection of the Prostate (TURP)+2 more
Cedar, United Kingdom 300
Not applicableStudy completedNCT00382356
What this trial is testing

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)

Who this might be right for
Benign Prostatic Hypertrophy
North Florida/South Georgia Veterans Health System 20
Post-approval studies (Phase 4)Study completedNCT02757963
What this trial is testing

Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 1,679